Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

AstraZeneca gets breakthrough status for Enhertu to treat NSCLC

pharmaceutical-technologyMay 20, 2020

Tag: AstraZeneca , NSCLC , Enhertu , Daiichi Sankyo

PharmaSources Customer Service